---
title: "ENWEI PHARMACEUTICAL's controlling shareholder's concerted action party plans to spend between 36 million and 72 million yuan to increase its shareholding"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/225560852.md"
description: "ENWEI PHARMACEUTICAL's controlling shareholder, Chengdu Jiewei, plans to increase its holdings of the company's A-shares within the next 6 months, with an increase amounting to between 36 million yuan and 72 million yuan. This move aims to enhance investor confidence. Chengdu Jiewei has obtained a special loan commitment from the Chengdu branch of SPD Bank, with the loan amount not exceeding 50 million yuan, specifically for the purpose of increasing shareholdings"
datetime: "2025-01-20T13:24:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/225560852.md)
  - [en](https://longbridge.com/en/news/225560852.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/225560852.md)
---

# ENWEI PHARMACEUTICAL's controlling shareholder's concerted action party plans to spend between 36 million and 72 million yuan to increase its shareholding

According to the announcement from Zhitong Finance APP, ENWEI PHARMACEUTICAL (301331.SZ) stated that its controlling shareholder Chengdu ENWEI Investment (Group) Co., Ltd. (referred to as "ENWEI Group") and its concerted action party Chengdu Jiewei Enterprise Management Co., Ltd. (hereinafter referred to as "Chengdu Jiewei/increasing shareholding entity") plan to increase their holdings of the company's A-shares within six months from the date of this announcement, based on their confidence in the company's future sustainable and stable development and recognition of its long-term investment value. The total amount of the increase will not be less than RMB 36 million and not exceed RMB 72 million.

According to the "Notice on the Establishment of Stock Repurchase and Increase Loan Matters" issued by the People's Bank of China, the National Financial Regulatory Administration, and the China Securities Regulatory Commission, the company meets the basic conditions for major shareholders to increase their stock holdings. The company recently received a notification letter from its controlling shareholder's concerted action party Chengdu Jiewei, stating that the Chengdu branch of Shanghai Pudong Development Bank Co., Ltd. issued a "Loan Commitment Letter" for a special loan for stock increase to Chengdu Jiewei, with the main contents as follows: 1. Loan amount: Under the premise of meeting relevant loan conditions, the Chengdu branch of Shanghai Pudong Development Bank Co., Ltd. will provide Chengdu Jiewei with a special loan not exceeding RMB 50 million. 2. Loan purpose: Chengdu Jiewei shall use the loan specifically for purchasing shares of the listed company ENWEI PHARMACEUTICAL Co., Ltd. (301331) through centralized bidding, with the loan funds adhering to the principle of "designated use, closed operation." 3. Loan term: 12 months

### Related Stocks

- [600000.CN](https://longbridge.com/en/quote/600000.CN.md)
- [301331.CN](https://longbridge.com/en/quote/301331.CN.md)

## Related News & Research

- [UAE-India economic, investment ties witnessing rapid growth: UIBC-UC](https://longbridge.com/en/news/286880497.md)
- [Prabhudas Lilladher Sticks to Its Buy Rating for Kalpataru Projects International Limited (KPIL)](https://longbridge.com/en/news/286845414.md)
- [China Upgrades Departure Tax Refund Policy for Foreign Visitors](https://longbridge.com/en/news/286868862.md)
- [Supporting industry infrastructure map launched to promote global supply chain integration](https://longbridge.com/en/news/286870981.md)
- [12:45 ETInventHelp Inventor Develops New Bandage Dispenser (TLS-1305)](https://longbridge.com/en/news/286946419.md)